ENANTA PHARMACEUTICALS INC·4

Mar 7, 6:50 PM ET

Russell Lesley 4

4 · ENANTA PHARMACEUTICALS INC · Filed Mar 7, 2022

Insider Transaction Report

Form 4
Period: 2022-03-03
Transactions
  • Award

    Stock Option (right to buy)

    2022-03-03+7,5007,500 total
    Exercise: $68.22Exp: 2032-03-03Common Stock (7,500 underlying)
Footnotes (1)
  • [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (March 3, 2022), with the final monthly installment vesting on the nearest trading day on the Nasdaq Global Select Market preceding the 2023 annual meeting of stockholders.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES